Senate's Pay-For-Delay Bill Would Weaken Drug Patents
This month several U.S. senators introduced the Preserve Access to Affordable Generics Act. The bill would expand Federal Trade Commission powers and alter the legal test governing drug patent settlements. See...To view the full article, register now.
Already a subscriber? Click here to view full article